Quince Therapeutics, Inc. Common Stock (QNCX) is a publicly traded Healthcare sector company. As of May 21, 2026, QNCX trades at $1.04 with a market cap of $16.22M and a P/E ratio of -0.64. QNCX moved +0.00% today. Year to date, QNCX is -96.22%; over the trailing twelve months it is -89.41%. Its 52-week range spans $0.79 to $45.50. Rallies surfaces QNCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
QNCX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. QNCX recently traded at $1.04. Market cap is $16.22M. P/E ratio is -0.64. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $1.04 |
| Market Cap | $16.22M |
| P/E Ratio | -0.64 |
| EPS | $-1.68 |
| Dividend Yield | 0.00% |
| 52-Week High | $45.50 |
| 52-Week Low | $0.79 |
| Volume | 97.21K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-80.77M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-80.77M | $-1.68 |
| 2024 | $0 | $-56.83M | $-1.31 |
| 2023 | $0 | $-31.39M | $-0.84 |
| 2022 | $0 | $-51.66M | $-1.54 |
QNCX analyst coverage data. Average price target: $0.00.